I maintain a 'Strong Buy' rating on McKesson with a fair value of $723 per share due to its robust oncology network and strong growth prospects. McKesson's minimal exposure to US-Mexico-Canada tariffs ...
Non-fuel retailing continued to play a growing role in earnings, as ADNOC Distribution expanded its convenience store ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results